Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population
다민족 집단에서 COVID-19 질병 중증도 및 사망률의 예측 인자로서 C5A 및 임상 마커 보완
Immunology
[키워드] Accuracy
acute kidney
addition
advance
albumin
allocation
Anemia
Asymptomatic
Biomarker
Biomarkers
Blood
blood count
blood indices
C-reactive protein
C5a
C5a anaphylatoxin
cause
CBC
clinical
Clinical severity
Coagulation
Cohort
common
Comorbidities
complement
complement component
complete blood count
coronavirus
coronavirus disease
coronavirus disease-2019
COVID-19
COVID-19 infection
COVID-19 patient
COVID-19 patients
death in COVID-19
develop
disease severity
Electrolytes
elevated
Endothelial dysfunction
ferritin
Glucose
help
hepatocellular injury
high risk
higher risk
Hypoalbuminemia
identify
IMPROVE
Infection
Inflammation
interleukin
interleukin-6
kidney
kidney function parameter
life-threatening
liver
lymphocyte
Lymphocyte count
lymphopenia
marker
Mild
Mortality
neutrophilic leukocytosis
Non-survivors
pandemic
parameter
parameters
Patient
patients
physiological
Population
predict
Predictive
procalcitonin
prognostic
recruited
resource
routine test
SARS-CoV-2
SARS-COV-2 infection
severe disease
severe symptom
severe symptoms
severity
split product
Stage
statistically significant
Stratification
survival
survival analysis
survivor
the disease
thrombosis
Treatment
vital signs
were measured
WHO
[DOI] 10.3389/fimmu.2021.707159 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.707159 PMC 바로가기 [Article Type] Immunology